Dual agonists typically target GLP-1R, GIP (glucose-dependent insulinotropic polypeptide) or IGF (insulin-like growth factor) receptors, while triple agonists target GLP-1R, GIPR, and the glucagon receptor (GCGR)
Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns
Understanding how GLP-1 medications work in the body helps put orforglipron unique profile in context
ScienceDirect , PLoS ONE , vol
The clinical significance of these differences for retatrutide specifically has not been studied, but experienced researchers report the most consistent results with abdominal injections following the standard dosage protocol